Krilogy Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.31M Sell
26,501
-2,423
-8% -$396K 0.12% 136
2026
Q2
$4.34M Sell
28,924
-3,512
-11% -$382K 0.13% 136
2026
Q1
$2.78M Buy
+32,436
New +$3.26M 0.09% 182

Other funds holding GH

Krilogy Financial's GH Position: Q3 2026 in Review

Krilogy Financial reduced its Guardant Health (GH) stake by 8.4% in Q3 2026, selling an estimated $396K and leaving 26,501 shares worth $4.31M. The position accounts for 0.12% of the portfolio, ranked #136.

Krilogy Financial first reported a position in GH in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.34M in Q2 2026. 99 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Krilogy Financial held 26,501 shares of Guardant Health worth $4.31M as of Q3 2026.
  • Krilogy Financial sold 2,423 Guardant Health shares in Q3 2026, an estimated $396K.
  • Guardant Health made up 0.12% of Krilogy Financial's portfolio in Q3 2026, its #136 holding.
  • Krilogy Financial first reported a position in Guardant Health in Q1 2026 and has held it in 3 quarters since.
  • Krilogy Financial's Guardant Health position peaked at $4.34M in Q2 2026.
  • 99 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.